TABLE 1.

Patient Characteristics, Biochemical Markers, and Tracer Uptake Scores

Patient no.Age (y)SexLocation of lesions (n)SymptomsRelevant medicationBiochemical marker*Uptake score
5-HIAAHVAMetaIMTOct
170FLiver (3)Abdominal pain9.703
273MLiver, abdominal (4)Diarrhea, flushing15.6112
376FLiver, abdominal, neck (10)Diarrhea, painInterferon-α33.55.772116
463FLiver, abdominal, lungs (11)Abdominal pain185.8822
544FLiver, abdominal (17)FlushingOctreotide65.85.8981136
659MLiver (11)FlushingInterferon-α37.32.260621
767FLiver, abdominal (4)Diarrhea2.805
867FLiver, abdominal, neck (8)Diarrhea, flushingOctreotide10.93.7143412
966MSupraclavicular (1)None8.922
1072MLiver, lung (1)None1.122
1163MLiver, abdominal, lungs (6)Diarrhea25.8248211
1264MAbdominal, mediastinal (9)Diarrhea, flushingOctreotide7.3514
1375FAbdominal, supraclavicular (7)Diarrhea4.607
1458MLiver, neck (5)Diarrhea, flushingOctreotide,  interferon-α1354.51291010
1574MAbdominal, lungs (9)FlushingOctreotide10.52.875112
1658MLiver, abdominal, bones (9)Abdominal pain3.4212
1764MLiver, abdominal (1)Diarrhea8.63.19212
1856FLiver, abdominal (12)NoneOctreotide51.2820
1955FAbdominal, supraclavicular (4)Diarrhea, flushing2.18.1117311
2050FAbdominal (1)Diarrhea4.3601
2169FLiver (8)Flushing91.59.81001113
2254FLiver, abdominal (4)Diarrhea, flushing1513.49895
  • * Selected markers: 5HIAA as serotonin, HVA as dopamine, and metanephrines (Meta) as catecholamine marker. Units are given in text.

  • Value elevated.

  • Oct = octreotide.